ARCHIVES

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

This article is from The Cancer Letter archive.

Vol. 39 No. 25 | June 21, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Commerce Dept. Open Radiation Standards Facility For Mammography Calibration

April 4, 1996

Radiologists Dispute Holland On NMR

April 20, 1984

In Turnaround, NCAB To Advise Screening Mammography for Women In Their Forties

March 28, 1997

Editorial: Ambiance Through Exclusion

May 20, 1994

Ovariectomy Without HRT Increases Death Rate

September 29, 2006

NCI Advisory Groups To Be Cut By One-Third

April 22, 1977